Duvall v. Bristol-Myers-Squibb Co.
Court of Appeals for the Fourth Circuit
1Opinion of the Court
OPINION
WILKINS, Circuit Judge:
These appeals require us to consider anew the effect of the express preemption provision contained in the Medical Device Amendments of 1976(MDA), Pub.L. No. 94-295, 90 Stat. 539, on Eugene Duvall’s state-law causes of action against Bristol-Myers-Squibb Company and its wholly owned subsidiary, Medical Engineering Corporation (collectively, “Bristol-Myers”). 1 See 21 U.S.C.A. § 360k(a) (West Supp.1996). In light of the recent decision of the Supreme Court in Medtronic, Inc. v. Lohr, — U.S. -, 116 S.Ct. 2240, 135 L.Ed.2d 700 (1996), we hold that § 360k(a) does not…
2Cases cited14 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- San Diego Building Trades Council v. GarmonSupreme Court of the United States · 1959
- Rice v. Santa Fe Elevator Corp.Supreme Court of the United States · 1947
- Cipollone v. Liggett Group, Inc.Supreme Court of the United States · 1992
- Medtronic, Inc. v. LohrSupreme Court of the United States · 1996
9 more not listed; retrieve them via the Exa API.
3Cited by19 opinions
- Donna Cisson v. C. R. Bard, IncorporatedCourt of Appeals for the Fourth Circuit · 2016
- Worthy v. Collagen Corp.Texas Supreme Court · 1998
- Huskey v. Ethicon, Inc.District Court, S.D. West Virginia · 2014
- Blanco v. Baxter Healthcare Corp.California Court of Appeal · 2008
- Lewis v. Johnson & JohnsonDistrict Court, S.D. West Virginia · 2014
14 more not listed; retrieve them via the Exa API.